Kamal Therapeutics
Kamal Therapeutics is a startup headquartered in Hingham, United States, founded in 2020. It has raised at least $13.8m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Kamal Therapeutics has raised at least $13.8m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Kamal Therapeutics sits inside the Boston and New England R&D ecosystem in the Global R&D Labs Directory.
Other startups in Hingham
Related
Questions and answers
What does Kamal Therapeutics do?
Kamal Therapeutics is classed in pharmaceuticals in its filings with the US Securities and Exchange Commission.
How much has Kamal Therapeutics raised?
At least $13.8m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Kamal Therapeutics based?
Kamal Therapeutics is headquartered in Hingham, United States.
When was Kamal Therapeutics founded?
Kamal Therapeutics was founded in 2020.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.